Updating the Canadian Hemophilia Outcomes–Kids' Life Assessment

Poster Presentations - 2019 - Haemophilia - Wiley Online Library

HHS Medical Hero: Mackenzie Weber - Hamilton Health Sciences

Factor XIII Deficiency: Practice Essentials, Background, Pathophysiology

Updating the Canadian Hemophilia Outcomes–Kids' Life Assessment Tool (CHO‐KLAT) in the era of extended half‐life clotting factor concentrates - Research and Practice in Thrombosis and Haemostasis

Health Canada approves Alhemo™, the first subcutaneous prophylactic treatment for people living with hemophilia B with inhibitors

Canadian Blood Services on LinkedIn: We are proud to have worked with David Page and the Canadian Hemophilia…

Describing the quality of life of boys with haemophilia in China

Up to 6 years of once-weekly prophylactic dosing of nonacog beta pegol (N9-GP) was associated with high adherence, with a low incidence of spontaneous bleeds in children with hemophilia B - ISTH

Exploring the utility of a novel point‐of‐care whole blood

Hemophilia patients surveyed in the Netherlands satisfied with care

PPT - Evidence Based Practice PowerPoint Presentation, free download - ID:190047